Comparative Biomedical Policy: Governing Assisted Reproductive
Technologies, Ivor Bleiklei, Malcolm L. Goggin and Christine Rothmayr,
eds., London: Routledge, 2004, pp. 284.
Few issues have the potential to combine elements of science fact and
science fiction as does the field of biomedical research and its offshoot,
assisted reproductive technologies (ART). As newspapers testify with
regularity, this area of science and medicine uniquely combines promises
for the improvement of human health but also exemplifies the dangers
associated with scientists playing god with the very the building blocks
of our species. Confronted with these stark opposites, public authorities
have entered the fray and have tried, with varied responses, to frame
these practices in such as way as to encourage and stimulate the positive
elements of this area of research and medicine, such as in vitro
fertilization, while cutting off or severely circumscribing the areas
which have been deemed immoral or unethical, such as human cloning. It is
where issues of morality or ethics enter the policy discourse that the
waters get murky and where, as a result, governments find the arbitration
between first-person experiences and societal norms the most
difficult.